Search Orphan Drug Designations and Approvals
-
Generic Name: | allogeneic ABCB5-positive limbal stem cells |
---|---|
Date Designated: | 03/28/2019 |
Orphan Designation: | Treatment of limbal stem cell deficiency |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
RHEACELL GmbH & Co. KG Im Neuenheimer Feld 517 Heidelberg, Baden-Württemberg Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-